HeartSciences (HSCS) Proxy filing summary

Executive summary

• Fortitude and an AI-powered medical technology business entered a definitive all-stock merger agreement; a special shareholder meeting will consider the transaction.

• A definitive proxy statement was filed on October 19, 2026, and will be mailed with a proxy card to shareholders entitled to vote.

Voting matters and shareholder proposals

• Shareholder approval is a condition to closing; failure to obtain the required approval could prevent or delay the proposed transaction.

Board of directors and corporate governance

• Fortitude, the other party, their directors and executive officers, and certain DCG executive officers may participate in the proxy solicitation; their identities and interests are described in the definitive proxy statement.